Regulus Therapeutics shares owned by Summit Investment Advisors
Quarter-by-quarter ownership of Regulus Therapeutics (RGLS) shares owned by Summit Investment Advisors
from 13F filings
Historical chart of Summit Investment Advisors investment in Regulus Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Regulus Therapeutics held by Summit Investment Advisors consolidated in one spreadsheet with up to 7 years of data
Download as csv Download as ExcelQuarterly reported holdings in Regulus Therapeutics by Summit Investment Advisors
Quarter filed | Position value | Share count | Share price at filing |
---|---|---|---|
2024-09-30 | $9.7k | 6.2k | 1.57 |
2024-06-30 | $11k | 6.2k | 1.79 |
More positions owned by Summit Investment Advisors
View all positions for Summit Investment Advisors